The challenges of the expanded availability of genomic information: an agenda setting-paper

Rapid advances in microarray and sequencing technologies are making genotyping and genome sequencing more affordable and readily available. There is an expectation that genomic sequencing technologies improve personalized diagnosis and personalized drug therapy. Concurrently, provision of direct-to-...

ver descrição completa

Detalhes bibliográficos
Autor principal: Borry, P. (author)
Outros Autores: Bentzen, H. B. (author), Budin-Ljøsne, I. (author), Cornel, M. C. (author), Howard, H.C. (author), Feeney, O. (author), Jackson, L. (author), Mascalzoni, D. (author), Mendes, A. (author), Peterlin, B. (author), Riso, B. (author), Shabani, M. (author), Skirton, H. (author), Sterckx, S. (author), Vears, D. F. (author), Wjst, M. (author), Felzmann, H. (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
Genomics
Clinical and research genomic data
Return of results
Data sharing
Informed consent
Direct-to-consumer genetic testing
Texto completo:http://hdl.handle.net/10071/15379
País:Portugal
Oai:oai:repositorio.iscte-iul.pt:10071/15379

Texto Completo

http://hdl.handle.net/10071/15379

Registos relacionados